ABSTRACT

Cardiac death is a major burden for cancer survivors, yet there is currently no effective treatment for doxorubicin (DOX)-induced cardiotoxicity. Here, we report that circ-ZNF609 knockdown knockdown had cardioprotective effects against DOX-induced cardiomyocyte toxicity. Mechanistically, circ-ZNF609 knockdown alleviated DOX-induced cardiotoxicity through attenuating cardiomyocyte apoptosis, reducing reactive oxygen species production, ameliorating mitochondrial nonheme iron overload. circ-ZNF609 inhibition blocked the elevation of RNA N6-methyladenosine (RNA m6A) methylation level in DOX-treated mice hearts, whereas m6A demethylase fat mass and obesity associated (FTO) acted as the downstream factor of circ-ZNF609. Moreover, the stability of circ-ZNF609 was regulated by RNA m6A methylation alteration, and suppression of RNA m6A methylation by methyltransferase like 14 (METTL14) modulated the function of circ-ZNF609. These data suggest that circ-ZNF609 inhibition represents a potential therapy for DOX-induced cardiotoxicity.

PMID:37426524 | PMC:PMC10322883 | DOI:10.1016/j.jacbts.2022.12.005

08:30

In reply to this message

PubMed articles on: Cardio-Oncology

The Emerging Role of Circular RNAs in Cardio-Oncology

JACC Basic Transl Sci. 2023 Jun 26;8(6):699-701. doi: 10.1016/j.jacbts.2023.04.004. eCollection 2023 Jun.

NO ABSTRACT

PMID:37426523 | PMC:PMC10322856 | DOI:10.1016/j.jacbts.2023.04.004

08:30

PubMed articles on: Cardio-Oncology

Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling

Acta Pharm Sin B. 2023 Jun;13(6):2680-2700. doi: 10.1016/j.apsb.2023.03.019. Epub 2023 Mar 25.